(Q41074444)

26 September 2017

title

Reduction of avian influenza virus shedding by administration of Toll-like receptor ligands to chickens (English)

1 reference

26 September 2017

0 references

1 reference

7

Shayan Sharif

1 reference

26 September 2017

Neda Barjesteh

1

1 reference

26 September 2017

Bahram Shojadoost

2

1 reference

26 September 2017

Jennifer T Brisbin

3

1 reference

26 September 2017

Mehdi Emam

4

1 reference

26 September 2017

Douglas C Hodgins

5

1 reference

26 September 2017

Éva Nagy

6

1 reference

26 September 2017

language of work or name

English

0 references

publication date

31 July 2015

1 reference

26 September 2017

1 reference

26 September 2017

volume

33

1 reference

26 September 2017

issue

38

1 reference

26 September 2017

page(s)

4843-4849

1 reference

Identifying innate immune pathways of the chicken may lead to new antiviral therapies

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Toll-like receptor signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Immunostimulatory properties of Toll-like receptor ligands in chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Toll-like receptors and their crosstalk with other innate receptors in infection and immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

The broad-spectrum antiviral functions of IFIT and IFITM proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Intrinsic Cellular Defenses against Virus Infection by Antiviral Type I Interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

The potential use of Toll-like receptor (TLR) agonists and antagonists as prophylactic and/or therapeutic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Antiviral applications of Toll-like receptor agonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Synergistic TLR2/6 and TLR9 activation protects mice against lethal influenza pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Unique features of chicken Toll-like receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Avian influenza virus vaccines containing Toll-like receptors 2 and 5 ligand adjuvants promote protective immune responses in chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Effects of ligands for Toll-like receptors 3, 4, and 21 as adjuvants on the immunogenicity of an avian influenza vaccine in chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

TLR ligands induce antiviral responses in chicken macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Prophylactic treatment with Toll-like receptor ligands enhances host immunity to avian influenza virus in chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Influenza: propagation, quantification, and storage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Effects of Lactobacilli on Cytokine Expression by Chicken Spleen and Cecal Tonsil Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Cytokine gene expression patterns associated with immunization against Marek's disease in chickens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Induction of chicken cytokine responses in vivo and in vitro by lipooligosaccharide of Campylobacter jejuni HS:10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Synthetic double-stranded RNA oligonucleotides are immunostimulatory for chicken spleen cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Effect of intranasal immunization with inactivated avian influenza virus on local and systemic immune responses in ducks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Avian-specific TLRs and downstream effector responses to CpG-induction in chicken macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

CpG-induced immunomodulation and intracellular bacterial killing in a chicken macrophage cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Characterization of chicken thrombocyte responses to Toll-like receptor ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Characterization of responses initiated by different Toll-like receptor 2 ligands in chicken spleen cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

MAPK/AP-1 activation mediates TLR2 agonist-induced SPLUNC1 expression in human lung epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Switching of the relative dominance between feedback mechanisms in lipopolysaccharide-induced NF-κB signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

The airway epithelium: soldier in the fight against respiratory viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Administration of TLR7 agonist, resiquimod, in different types of chicken induces a mixed Th1 and Th2 response in the peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Synergy of lipopolysaccharide and resiquimod on type I interferon, pro-inflammatory cytokine, Th1 and Th2 response in chicken peripheral blood mononuclear cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Critical role of constitutive type I interferon response in bronchial epithelial cell to influenza infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Intrinsic antiviral immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Chicken interferon-inducible transmembrane protein 3 restricts influenza viruses and lyssaviruses in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

Cytosolic sensing of viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

The differential antiviral activities of chicken interferon α (ChIFN-α) and ChIFN-β are related to distinct interferon-stimulated gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

The interferon inducible gene: Viperin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.070

10.1016/J.VACCINE.2015.07.070

7 January 2021

Identifiers

DOI

1 reference

26 September 2017

1 reference